Brain tumor trial combines virus and immunotherapy to fight glioblastoma
NCT ID NCT05084430
First seen Jan 28, 2026 · Last updated May 14, 2026 · Updated 8 times
Summary
This study tests a new treatment for people with aggressive brain tumors like glioblastoma. It combines a genetically modified virus (M032) that attacks tumor cells and boosts the immune system, with the immunotherapy drug pembrolizumab. The goal is to see if this combination is safe and helps people live longer. About 28 adults whose tumors have come back after standard treatment will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Alabama at Birmingham
RECRUITINGBirmingham, Alabama, 35294, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.